New patent, WO 2016001885, Dr Reddy’s Laboratories Ltd, Eliglustat hemitartarate
WO 2016001885 DR. REDDY’S LABORATORIES LIMITED [IN/IN]; 8-2-337, Road No. 3, Banjara Hills, Telangana, India Hyderabad 500034 (IN) VELAGA, Dharma Jagannadha Rao; (IN). PEDDY, Vishweshwar; (IN). VYALA,...
View ArticleSKLB 1028, a novel oral multikinase inhibitor of EGFR, FLT3 and Abl,
SKLB 1028 IND Filed A multi-targeted inhibitor potentially for the treatment of leukemia and non small cell lung cancer. SKLB-1028 Si Chuan University, 四川大学 CAS 1350544-93-2...
View ArticleAcotiamide
Acotiamide hydrochloride trihydrate CAS#: 773092-05-0 (Acotiamide HCl hydrate, 1:1:3); 185104-11-4(Acotiamide HCl, 1:1); 185106-16-5 (Acotiamide free base) Chemical Formula: C21H37ClN4O8S...
View ArticlePonalrestat
Ponalrestat Phase III An aldose reductase inhibitor potentially for the treatment of diabetes. Imperial Chemical Industries Limited innovator ICI-128436; MK-538; ICI-plc CAS No.72702-95-5 Statil;...
View ArticleVAL-083
VAL-083 (1R,2S)-1-((R)-oxiran-2-yl)-2-((S)-oxiran-2-yl)ethane-1,2-diol Galactitol, 1,2:5,6-dianhydro- 1,2:5,6-Dianhydrodulcitol 1,2:5,6-Dianhydrogalactitol 1,2:5,6-Diepoxydulcitol...
View ArticleAliskiren
ALISKIREN (2S,4S,5S,7S)-5-amino-N-(2-carbamoyl-2,2-dimethylethyl)-4-hydroxy-7-{[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl}-8-methyl-2-(propan-2-yl)nonanamide, CAS 173334-57-1, base CAS...
View ArticleAT 9283
AT9283, AT 9283 N-cyclopropyl-N’-[3-[6-(4-morpholinylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]urea...
View ArticleBreaking and Making of Olefins Simultaneously Using Ozonolysis: Application...
A simple and practical one-pot, two-directional approach to access olefinic esters through simultaneous breaking and making of olefins using ozonolysis of alkenyl aryl selenides is disclosed. The...
View ArticleLupin Ltd, Patent, Pitavastatin, WO2014203045
Lupin Ltd, Patent, Pitavastatin, WO2014203045 A NOVEL, GREEN AND COST EFFECTIVE PROCESS FOR SYNTHESIS OF TERT-BUTYL (3R,5S)-6-OXO-3,5-DIHYDROXY-3,5-O-ISOPROPYLIDENE-HEXANOATE ROY, Bhairabnath; (IN)....
View ArticleFDA´s Emerging Technology Applications Program – Draft Guidance
FDA´s Emerging Technology Applications Program – Draft Guidance The FDA recently published a draft guidance for industry on the “Advancement of Emerging Technology Applications”. The draft guidance...
View ArticleWhat was the drug in Clinical Trial Tragedy In France Jan 2016
BIA 10-2474 3-(1-(cyclohexyl(methyl)carbamoyl)-1H-imidazol-4-yl)pyridine 1-oxide Bial-Portela & Ca. S.A. BIA 10-2474 is an experimental fatty acid amide hydrolase inhibitor[1] developed by the...
View ArticleFresolimumab
Fresolimumab GC 1008, GC1008 UNII-375142VBIA cas 948564-73-6 Structure immunoglobulin G4, anti-(human transforming growth factors beta-1, beta-2 (G-TSF or cetermin) and beta-3), human monoclonal...
View Article5-Bromo-1-methyl-1H-imidazole-4-carbonitrile
Source: 5-Bromo-1-methyl-1H-imidazole-4-carbonitrileFiled under: Uncategorized
View ArticleNew TRPV1 Antagonist From Neurogen Corporation
MK ? NGD? MK 2295; NGD 8243 may be??????? CAS 878811-00-8 FREE FORM Molecular Formula: C27H31FN6O2 Molecular Weight: 490.572443 g/mol...
View ArticlePF 04995274, a 5-HT4Partial Agonist
PF-04995274, (R)-4-((4-(((4-(Tetrahydrofuran-3-yloxy)-1,2-benzisoxazol-3-yl)oxy)methyl)piperidin-1-yl)methyl)tetrahydro-2H-pyran-4-ol...
View ArticleNew Website ECA Validation Group: Version 02 of ECA´s Good Practice Guide on...
The ECA Validation Group was founded in autumn 2011 by representatives of the pharmaceutical industry after ECA´s 4th European GMP Conference. The mission of the group is to assemble knowledge on...
View ArticleTalazoparib, BMN 673
Talazoparib, BMN-673, MDV-3800 (2S,3S)-methyl-7-fluoro-2-(4-fluorophenyl)-3-(1-methyl-1H-1,2,4-triazol-5-yl)-4-oxo-1,2,3,4-tetrahydroquinoline-5-carboxylate...
View ArticleVASICINE, (peganine)
. Vasicine (peganine) is a quinazoline alkaloid. It is the active compound of Justicia adhatoda, after which the chemical is named. Vasicine has been compared to theophylline both in vitro and in...
View ArticleNIZATIDINE
Nizatidine is a histamine H2 receptor antagonist that inhibits stomach acid production, and is commonly used in the treatment of peptic ulcer disease and gastroesophageal reflux...
View Article